Goldman Sachs
ASMB icon

Goldman Sachs’s Assembly Biosciences ASMB Stock Holding History

Goldman Sachs’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,083
Closed -$483K – 5221
2018
Q3 		$483K Hold
1,083
– – ﹤0.01% 4441
2018
Q2 		$510K Buy
+1,083
New +$573K ﹤0.01% 4495

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Goldman Sachs's ASMB Position: Q1 2026 in Review

Goldman Sachs increased its Assembly Biosciences (ASMB) stake by 4.1% in Q1 2026, buying an estimated $40.2K and bringing the position to 36,205 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #5085.

Goldman Sachs first reported a position in ASMB in Q1 2014 and has held it in 36 quarters since. The position peaked at $3.13M in Q2 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Goldman Sachs held 36,205 shares of Assembly Biosciences worth $1M as of Q1 2026.
  • Goldman Sachs bought 1,411 Assembly Biosciences shares in Q1 2026, an estimated $40.2K.
  • Assembly Biosciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5085 holding.
  • Goldman Sachs first reported a position in Assembly Biosciences in Q1 2014 and has held it in 36 quarters since.
  • Goldman Sachs's Assembly Biosciences position peaked at $3.13M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.